The reduced IFN receptor binding affinity of the attenuated IFN-α2b molecules of modakafusp alfa reduces the potential for off-target binding and toxicity (18), which is a limitation of IFNα treatments historically used in melanoma (9, 19). This evidence concerns the gene IFNA2 and melanoma.